1.
Tahir Siddique, Sadaf Farzand, Marryam Khalid, Rizwan Ahmad, Kashif Aziz Ahmad, Muhammad Maqsood. Efficacy and Safety of Once-Weekly Semaglutide versus Tirzepatide in Type 2 Diabetes: A 24-Week Randomized Clinical Trial. JHWCR. 2025;3(1):1-8. doi:10.61919/qxt0b644